Fitness Ozempic, Wegovy: India’s cheap weight-loss drugs could reshape global obesity fight Published 3 months ago on March 18, 2026 By News24x7 Share Tweet With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market. Related Topics: Up Next ‘Club vibes without the hangover’: The twenty-somethings going out – in the gym Don't Miss Jersey woman felt ‘responsibility’ to share diabetes diagnosis Continue Reading Latest Travel18 minutes ago Norwegian Air To Buy Nordic Leisure Travel Group in $843m Bet on End-to-End Travel Entertainment24 minutes ago Paul O’Grady life story show set for national tour Sports24 minutes ago Wimbledon 2026: Serena Williams and Venus Williams receive doubles wildcard Sports27 minutes ago World Cup 2026: Ghana government challenges Thomas Partey’s visa denial in court Bussiness49 minutes ago Do online saving methods really work? Travel51 minutes ago Etihad offers free medical travel insurance to visitors to Abu Dhabi – Wanderlust Entertainment55 minutes ago Tina Daheley: Newsreader to leave Radio 2 breakfast show Shopping58 minutes ago High pressure sales tactics to be aware of Sports1 hour ago Swansea City to make Crystal Palace’s Ben Stevens sporting director World1 hour ago California wildfires burn near passing vehicles